This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Mary K Yagodich: Innovator in Respiratory Syncytial Virus Research
Introduction
Mary K Yagodich is a prominent inventor based in Bryn Mawr, Pennsylvania. She has made significant contributions to the field of virology, particularly in the development of vaccines against respiratory syncytial virus (RSV). Her innovative work has the potential to impact public health positively.
Latest Patents
Mary K Yagodich holds a patent for a live, attenuated respiratory syncytial virus. This invention features live, attenuated RSV that is useful as a vaccine against RSV infection and the development of severe RSV-associated illnesses. The disclosed viruses are designed to be nonpathogenic when administered to a subject while retaining the antigenic and immunogenic properties of wild-type RSV.
Career Highlights
Mary K Yagodich is associated with Merck Sharp & Dohme Corp., a leading pharmaceutical company. Her work at Merck has allowed her to focus on developing innovative solutions to combat viral infections, particularly RSV.
Collaborations
Throughout her career, Mary has collaborated with notable colleagues, including Michael P Citron and Daniel J Distefano. These collaborations have enhanced her research and contributed to the advancement of vaccine development.
Conclusion
Mary K Yagodich's contributions to the field of virology, particularly through her patent on RSV vaccines, highlight her role as an innovator in medical research. Her work continues to pave the way for advancements in public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile